000			02155 a2200613 4500
005			20250515110205.0
264		0	_c20080520
008			200805s 0 0 eng d
022			_a0301-472X
024	7		_a10.1016/j.exphem.2007.12.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchulze, Astrid
245	0	0	_aAltered phenotype of natural killer cell subsets after haploidentical stem cell transplantation. _h[electronic resource]
260			_bExperimental hematology _cApr 2008
300			_a378-89 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntigens, CD _xbiosynthesis
650	0	4	_aAntigens, CD34 _xbiosynthesis
650	0	4	_aAntigens, Differentiation, T-Lymphocyte _xbiosynthesis
650	0	4	_aCD56 Antigen _xbiosynthesis
650	0	4	_aChimerism
650	0	4	_aFas Ligand Protein _xblood
650	0	4	_aFemale
650	0	4	_aHLA-DR Antigens _xbiosynthesis
650	0	4	_aHaplotypes _ximmunology
650	0	4	_aHistocompatibility Testing
650	0	4	_aHumans
650	0	4	_aImmunophenotyping
650	0	4	_aInterleukin-15 _xblood
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aLectins, C-Type
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _ximmunology
650	0	4	_aLeukemia, Myeloid, Acute _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPostoperative Complications
650	0	4	_aProspective Studies
650	0	4	_aRecurrence
650	0	4	_aStem Cell Transplantation _xmethods
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand _xblood
650	0	4	_aTreatment Outcome
700	1		_aSchirutschke, Holger
700	1		_aOelschlägel, Uta
700	1		_aSchmitz, Marc
700	1		_aFüssel, Monika
700	1		_aWassmuth, Ralf
700	1		_aEhninger, Gerhard
700	1		_aBornhäuser, Martin
700	1		_aPlatzbecker, Uwe
773	0		_tExperimental hematology _gvol. 36 _gno. 4 _gp. 378-89
856	4	0	_uhttps://doi.org/10.1016/j.exphem.2007.12.006 _zAvailable from publisher's website
999			_c17767164 _d17767164